|
|
| | (2S,3R,4S)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxymethyl)-2-methoxy-3,4-dihydro-2H-pyran-3,4-diol Basic information |
| Product Name: | (2S,3R,4S)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxymethyl)-2-methoxy-3,4-dihydro-2H-pyran-3,4-diol | | Synonyms: | (2S,3R,4S)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxymethyl)-2-methoxy-3,4-dihydro-2H-pyran-3,4-diol;β-L-threo-Hex-4-enopyranoside, methyl 1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-4-deoxy-;Ertugliflozin Des Hydroxy Impurity;(2S,3R,4S)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-3,4-dihydroxy-2-methoxy-3,4-dihydro-2H-pyran-6-carbaldehyde;Ertugliflozin Impuity 7;Ertugliflozin Impurity 18;Linagliptin Impurity 124 | | CAS: | 1528636-45-4 | | MF: | C22H25ClO6 | | MW: | 420.89 | | EINECS: | | | Product Categories: | | | Mol File: | 1528636-45-4.mol |  |
| | (2S,3R,4S)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxymethyl)-2-methoxy-3,4-dihydro-2H-pyran-3,4-diol Chemical Properties |
| Boiling point | 588.8±50.0 °C(Predicted) | | density | 1.35±0.1 g/cm3(Predicted) | | pka | 12.21±0.70(Predicted) |
| | (2S,3R,4S)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxymethyl)-2-methoxy-3,4-dihydro-2H-pyran-3,4-diol Usage And Synthesis |
| Uses | (2S,3R,4S)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxymethyl)-2-methoxy-3,4-dihydro-2H-pyran-3,4-diol has research applications in treatment of type-2 diabetes |
| | (2S,3R,4S)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxymethyl)-2-methoxy-3,4-dihydro-2H-pyran-3,4-diol Preparation Products And Raw materials |
|